This HTML5 document contains 49 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q63966241
rdf:type
wikibase:Item
schema:description
scientific article published on 01 March 2008 artículu científicu espublizáu en marzu de 2008 наукова стаття, опублікована в березні 2008 im März 2008 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel գիտական հոդված հրատարակված 2008 թվականի մարտի 1-ին
p:P577
wds:Q63966241-261AAF02-DCED-4B75-9750-41EC51289C12
wdt:P577
2008-03-01T00:00:00Z
p:P2093
wds:Q63966241-25B37DE8-EB66-4C8F-AB37-66468DAEC25E wds:Q63966241-49EADF03-1E1A-4183-8DAB-294FB345A7B3 wds:Q63966241-36A724D2-DC9C-4972-8EB1-757002EBEB1F wds:Q63966241-F5C76E4E-54E8-4AE7-8FA5-B5DADD7E3D09 wds:Q63966241-BBD5B19A-16FD-4515-9117-276ED7A237B0
wdt:P2093
J-L Moreau P Beuzeboc X Rebillard P Richaud A Benchikh El Fegoun
rdfs:label
PSA et suivi après traitement du cancer de la prostate PSA et suivi après traitement du cancer de la prostate
skos:prefLabel
PSA et suivi après traitement du cancer de la prostate PSA et suivi après traitement du cancer de la prostate
schema:name
PSA et suivi après traitement du cancer de la prostate PSA et suivi après traitement du cancer de la prostate
p:P50
wds:Q63966241-065491D1-CC6D-4C84-B654-501AEEC60758
wdt:P50
wd:Q56531008
p:P1476
wds:Q63966241-1703612D-7A94-42EC-9FF6-F570DF3A8E6D
wdt:P1476
[PSA and follow-up after treatment of prostate cancer]
p:P304
wds:Q63966241-415FE89D-7080-4409-B19C-BD0983EEE86A
wdt:P304
137-144
p:P31
wds:Q63966241-D3557778-C297-4EFA-9DEE-A8BCC0262578 wds:Q63966241-3795a3b8-e612-42a6-b61d-d28898831a36
wdt:P31
wd:Q7318358 wd:Q13442814
p:P921
wds:Q63966241-C809A765-A4AD-4B38-BF36-AB0585F4F70F
wdt:P921
wd:Q105650
p:P698
wds:Q63966241-A712BA26-8AC3-45D0-9252-ADC9124E52C3
wdtn:P698
n7:18472065
wdt:P698
18472065
p:P1433
wds:Q63966241-5B9A8FFF-166A-4AF6-AACB-56508CA002DE
wdt:P1433
wd:Q27710086
p:P433
wds:Q63966241-F12C1CA3-E227-4EE2-B972-D9846FE968AA
p:P478
wds:Q63966241-97F44D5B-F0E1-48BF-9F8A-83EA7F68E3D5
wdt:P433
3
wdt:P478
18
p:P356
wds:Q63966241-C93B9985-F505-4EEC-B0F6-0013E3DFD01C
wdtn:P356
n12:J.PUROL.2007.12.010
wdt:P356
10.1016/J.PUROL.2007.12.010